Home
Conditions
Pheochromocytoma

Clinical trial condition

Pheochromocytoma

Explore clinical trials studying Pheochromocytoma. Study availability and eligibility vary by location and protocol.

112 public trials 32 recruiting studies

Refine in advanced search Browse all conditions

Pheochromocytoma trial results

Active, not recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions: Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

Anchorage Radiation Therapy Center Anchorage, Alaska, United States

View all 1007 locations

View Trial Details

Active, not recruiting

DOTATOC PET/CT for Imaging NET Patients

NCT03583528

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +66 more
Locations: BC Cancer Vancouver, British Columbia, Canada

View Trial Details

Active, not recruiting

Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma

NCT03839498

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Columbia University Irving Medical Center New York, United States

View Trial Details

Active, not recruiting

LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)

NCT03946527

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: Columbia University Irving Medical Center New York, United States

Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Active, not recruiting

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

NCT04711135

Conditions: Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors, Neoplasms, +7 more
Locations: University of Kentucky Lexington, Kentucky, United States

Cincinnati Children's Hospital Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Centre Léon Berard Lyon, France

View Trial Details

Active, not recruiting

Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death

NCT05446779

Conditions: ACTH Syndrome, Ectopic, Adrenal Cushing Syndrome, Adrenal Gland Diseases, +17 more
Locations: Endocrinology, Helsinki University Hospital and University of Helsinki Helsinki, Finland

View Trial Details

Completed

Development of a Tele-monitoring Program for Patients Undergoing Surgery for Pheochromocytoma and / or Paraganglioma

NCT04573816

Conditions: Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Hopital européen Georges Pompidou Paris, France

View Trial Details

Completed

Development and Clinical Application of a Novel Imaging Grading System for Pheochromocytoma and Paraganglioma (PPGL)

NCT07412158

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Department of Urology, Peking University First Hospital, Beijing, 100034 Beijing, China

View Trial Details

Completed

Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma

NCT01022515

Conditions: Cardiovascular Diseases, Essential Hypertension, Hypertension, +9 more
Locations: CIC 9301 Lille, France

Endocrinology Department Lille, France

Inserm U982/EA 4310; Rouen University (DC2N) Mont-Saint-Aignan, France

Cardiology Department Paris, France

View Trial Details

Completed

Abdominal Circumference as a Predictor of Operative Time in Retroperitoneal Adrenalectomy for Pheochromocytoma

NCT07339241

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +6 more
Locations: Not specified

View Trial Details

Pheochromocytoma

Pheochromocytoma trial results

Related conditions